Latest Strategic Growth News

K2 Asset Management Holdings Ltd has won a significant new investment mandate worth approximately A$242 million, expected to increase its revenue by around 15%, reinforcing its strategic growth trajectory.

OM Holdings delivered a robust production update for Q4 2024, with ferrosilicon output rising sharply despite manganese ore price declines and operational challenges. The company also secured a top sustainability award and made significant debt repayments.

AnteoTech has marked a pivotal quarter with its first commercial Ultranode™ order shipped to Mercedes-Benz and a $4.3 million capital raise to accelerate growth in clean energy and life sciences.

Butn Limited has posted record quarterly revenue and platform originations for Q2 FY25, alongside sustained positive operating cash flow, signaling robust growth and strategic expansion into crypto-backed lending.

Thor Energy PLC advances its clean energy ambitions through a strategic acquisition in South Australia's hydrogen sector and promising uranium drilling results in the US.

Volt Resources Limited has successfully repaid a AU$500,000 loan to RiverFort Global Opportunities, underscoring its financial discipline amid ongoing graphite project developments.

4DMedical has signed a landmark commercial agreement with Qscan Radiology Clinics, marking its first Australian contract to integrate both Pulmonary Function and Pulmonary Structure imaging products.

Coventry Group reports a slight dip in H1 FY25 sales but manages a modest EBITDA increase, buoyed by a successful ERP upgrade and strategic growth initiatives.

Synlait Milk Limited projects a return to profitability in HY25 with EBITDA guidance between $58 million and $63 million, underpinned by strategic growth and cost control. The company also enhances its financial incentives to secure South Island milk supply for the next three seasons.

Bioxyne Limited has raised its FY2025 revenue forecast to $25 million, driven by a remarkable 267% increase in first-half revenue and strong momentum from its subsidiary Breathe Life Sciences.

Memphasys Limited marks a pivotal quarter with the completion of clinical trials for its Felix™ System, strategic market expansions in Greater China and the Middle East, and a successful capital raise to fuel growth.

Westgold Resources Limited achieved record gold production of 80,886 ounces in Q2 FY25, driving a robust net mine cash flow of $45 million and securing a $200 million corporate facility to fuel growth.